🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
FGFR1-rearranged myeloid/lymphoid neoplasms are a rare hematologic malignan...
Status
Recruiting
Location
First Affiliated Hospital of Soochow University
Start Date
2022-09-01
Trial ID
NCT05521204
Treatments Being Tested
To study the minimal residual disease (MRD) clearance rate of olverembatini...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-03-14
Trial ID
NCT07443488
Treatments Being Tested
This phase II trial studies how well the combination of based decitabine an...
Status
Unknown
Location
Department of Hematology, Nanfang Hospital, Southern Medical University,
Start Date
2021-12-01
Trial ID
NCT05376852
Treatments Being Tested
To find out if giving blinatumomab as injections under the skin and olverem...
Status
Not Yet Recruiting
Location
MD Anderson Cancer Center
Start Date
2026-08-27
Trial ID
NCT07178912
Treatments Being Tested
This open-label, non-randomized, phase II exploratory study aims to evaluat...
Status
Recruiting
Location
Blood diseases hospital
Start Date
2026-05-30
Trial ID
NCT07454226
ABC study is a phase 2, single-arm, open-label study of Olverembatinib, CD3...
Status
Recruiting
Location
Dept of Hematology, Nanfang Hospital, Southern Medical University
Start Date
2024-02-01
Trial ID
NCT06220487
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of HQP1351 in patient...
Status
Unknown
Location
Peking University People's Hospital
Start Date
2019-04-08
Trial ID
NCT03883100
Treatments Being Tested
The introduction of TKIs has greatly improved the prognosis of Ph+ ALL pati...
Status
Completed
Location
Institute of Hematology & Blood Diseases Hospital
Start Date
2022-10-08
Trial ID
NCT05594784
Treatments Being Tested
This study is a Multi-center, Open-label Phase 1 Study to Determine the Rec...
Status
Recruiting
Location
Sun-Yat Sen University Cancer Center
Start Date
2018-07-11
Trial ID
NCT03594422
Treatments Being Tested
An international multicenter, open, single-arm pivotal registration phase I...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2024-11-11
Trial ID
NCT06640361
Treatments Being Tested